Sign in

CIK 0001682852 · Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813467528
Phone
6177146500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,875,818
in 4 filings, $33.9M under 10b5-1 plans

Net −$33,875,818. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-27 Klinger Shannon Thyme Chief Legal Officer Option exercise +2,653 26,018
2025-02-27 Klinger Shannon Thyme Chief Legal Officer Shares withheld for taxes −1,283 $33.58 $43K 24,735
2025-02-27 Klinger Shannon Thyme Chief Legal Officer Option exercise · Restricted Stock Units −3,094 9,283
2025-02-27 Klinger Shannon Thyme Chief Legal Officer Option exercise · Restricted Stock Units −2,653 0
2025-02-27 Hoge Stephen President Option exercise +5,746 1,452,855
2025-02-27 Hoge Stephen President Shares withheld for taxes −2,779 $33.58 $93K 1,450,076
2025-02-27 Hoge Stephen President Option exercise · Restricted Stock Units −5,746 17,241
2025-02-12 Klinger Shannon Thyme Chief Legal Officer Grant or award +2,047 22,493
2025-02-12 Klinger Shannon Thyme Chief Legal Officer Shares withheld for taxes −1,068 $30.93 $33K 21,425

Page 20 of 20 · 389 trades